Recently, BMI-1, a member of the PcG group, has been found to be over-expressed in a variety of human cancers, including human cervical carcinoma [25], [29], [30] resulting in the induction of auto-antibodies that our studies indicate may be clinical useful. This evidence concerns the gene BMI1 and cervical carcinoma.